Related pages: Possible side effects may include nausea, vomiting, diarrhea, constipation, decreased appetite, or fatigueparticularly during dose adjustments
10.1186/s13020-025-01166-2 270 XuG.JinJ.FuZ.WangG.LeiX.XuJ.et al (2025b)
Discussion The present study used the findings of the SUSTAIN 7 RCT of 1201 patients with T2D to compare the cost of bringing a patient to each of five defined clinical targets in the trial with injectable once-weekly semaglutide 0.5 mg relative to once-weekly dulaglutide 0.75 mg
This unimolecular dual incretin, which was derived from a mixed sequence of GLP- 1 and GIP, showed improved antihyperglycemic and insulinotropic activity compared to selective GLP- 1 agonists
The decision to scrap the plan by the budget-slashing Trump administration could make things much harder for millions of people with obesity, however
doi: 10.1016/S0015-0282(02)04948-8 124 LuJWangZCaoJChenYDongY